![]() |
市場調查報告書
商品編碼
1625204
2030 年微導管市場預測:按產品類型、材料類型、程序、最終用戶和地區進行的全球分析Micro Catheters Market Forecasts to 2030 - Global Analysis By Product Type (Single Lumen, Dual Lumen, Triple Lumen, Multidirectional and Other Product Types), Material Type, Procedure, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球微導管市場規模將達到 21 億美元,預計到 2030 年將達到 31 億美元,預測期內複合年成長率為 6.5%。
微導管是一種小型軟性管,用於醫療程序中,用於處理或收集體內特定區域的樣本。它們的直徑通常小於 2 毫米,旨在精確進入狹窄或難以到達的區域,例如血管或神經系統。微導管通常用於介入放射學、心臟病學和神經病學等領域,用於栓塞、切片檢查和藥物傳輸等手術,以微創方式改善患者的治療效果。
根據《2023年世界心臟報告》,全球有超過5億人受到心血管疾病的影響,2021年將有2,050萬人死亡,幾乎佔全球死亡人數的三分之一。這比先前估計值的 1.21 億 CVD 相關死亡人數有所增加,凸顯了日益嚴重的全球健康危機。
慢性病增加
心血管疾病、糖尿病、神經系統疾病等慢性病的盛行率不斷上升,推動了市場需求。這些先進的設備可實現微創手術,具有恢復更快、併發症更少等優點。隨著全球人口老化和慢性病的盛行率增加,微導管市場正在擴大,這些設備在改善患者預後和提高治療效率方面發揮關鍵作用。
產品缺陷和召回
市場上的產品缺陷或召回可能會產生嚴重的不利影響,包括消費者信心下降、市場佔有率下降、監管力度加大。除了供應鏈潛在的中斷之外,此類事件還可能因賠償成本和訴訟而給製造商帶來經濟損失。此外,產品缺陷引起的安全問題可能會阻礙醫療保健專業人員使用這些設備,從而阻礙市場成長和創新。
微創手術日益偏好青睞
對微創手術日益成長的偏好正在顯著推動市場發展。患者和醫療保健專業人員越來越喜歡這些手術,因為它們比傳統手術具有優勢,包括更快的恢復時間、更低的感染風險和更少的創傷。微導管能夠實現精確、有針對性的治療,滿足了這一趨勢並提高了治療效率。隨著對微創解決方案的需求不斷增加,微導管在現代醫學的發展中發揮關鍵作用。
缺乏熟練的專業人員
市場上缺乏熟練的專業人員構成了重大挑戰,因為它阻礙了這些先進醫療設備的有效使用和實施。訓練和專業知識不足可能會導致手術不當、併發症風險增加以及患者預後不佳。這種技能差距還會限制市場創新和擴張的潛力,減緩微創治療的成長,並降低醫療保健效率。
COVID-19 的爆發對市場產生了負面影響,導致擇期手術的延誤和全球供應鏈的中斷。醫院優先考慮緊急護理,減少了對非緊急護理的需求。此外,旅行和國際貿易限制也影響了醫療設備的分配。然而,疫情也可能加速遠端醫療和遠距監測的普及,間接增加對微導管等微創手術的需求。
預計單流明部分在預測期內將是最大的
預計單流明細分市場將在預測期內佔據最大的市場佔有率。其簡單緊湊的設計使其成為微創治療的理想選擇,可精確進入目標區域,特別是在血管成形術和神經血管介入治療等手術中。這些導管的需求不斷成長,因為它們能夠有效縮短患者康復時間、最大限度地減少併發症並能夠有效治療各種慢性疾病。
預計神經血管部分在預測期內複合年成長率最高
神經血管段預計在預測期內複合年成長率最高,因為它是治療動脈瘤和中風等疾病的重要設備。微導管精確地引導脆弱的神經血管通路並實現微創治療。由於導管設計的進步、改善患者的治療效果、縮短恢復時間以及為傳統手術方法提供更安全的替代方案,它們在神經血管介入治療中的使用越來越多。
由於醫療基礎設施的進步和對微創手術的需求不斷增加,預計北美地區在預測期內將佔據最大的市場佔有率。該地區強大的醫療保健系統和微導管設計創新正在支持市場擴張。此外,該地區人口老化和醫療成本上升導致對這些設備的需求增加,使其成為微導管製造商的重要市場。
預計亞太地區在預測期內將實現最高成長率。擴大醫療基礎設施,特別是在新興市場,正在改善患者獲得先進醫療服務的機會。它也提高了人們對微創手術益處的認知。此外,微導管設計開發的進步,包括靈活性、耐用性和可操縱性的提高,使這些設備能夠更有效地治療各種病症,從而進一步提高其採用率。
According to Stratistics MRC, the Global Micro Catheters Market is accounted for $2.1 billion in 2024 and is expected to reach $3.1 billion by 2030 growing at a CAGR of 6.5% during the forecast period. Micro catheters are small, flexible tubes used in medical procedures to deliver treatments or collect samples from specific areas within the body. Typically measuring less than 2 millimeters in diameter, they are designed for precision access to narrow or hard-to-reach areas, such as blood vessels or the nervous system. Micro catheters are commonly used in interventional radiology, cardiology, and neurology for procedures like embolization, biopsy, or drug delivery, offering minimal invasiveness and improved patient outcomes.
According to the WORLD HEART REPORT 2023, over half a billion people worldwide were affected by cardiovascular diseases, which caused 20.5 million deaths in 2021, accounting for nearly a third of all global deaths. This marked an increase from the previous estimate of 121 million CVD-related deaths, emphasizing the growing global health crisis.
Increasing prevalence of chronic diseases
The increasing prevalence of chronic diseases, such as cardiovascular conditions, diabetes, and neurological disorders, is driving the demand for market. These advanced devices enable minimally invasive procedures, offering benefits like faster recovery and reduced complications. As the aging population grows and the incidence of chronic diseases rises globally, the micro catheter market is expanding, with these devices playing a crucial role in improving patient outcomes and enhancing treatment efficiency.
Product failures and recalls
Product failures and recalls in the market can have severe negative effects, including diminished consumer trust, reduced market share, and increased regulatory scrutiny. Such incidents may lead to financial losses for manufacturers due to compensation costs and lawsuits, alongside potential disruptions in the supply chain. Furthermore, safety concerns raised by product defects could discourage healthcare professionals from using these devices, hampering market growth and innovation.
Rising preference for minimally invasive procedures
Rising preference for minimally invasive procedures is significantly boosting the market. Patients and healthcare professionals increasingly favor these techniques due to their benefits, such as shorter recovery times, reduced risk of infections, and fewer traumas compared to traditional surgeries. Micro catheters, enabling precise and targeted treatments, align with this trend, offering enhanced procedural efficiency. As demand for less invasive solutions grows, micro catheters play a critical role in advancing modern medical practices.
Lack of skilled professionals
The lack of skilled professionals in the market poses a significant challenge, as it can hinder the effective use and adoption of these advanced medical devices. Inadequate training or expertise may lead to improper procedures, increased risk of complications, and suboptimal patient outcomes. This skills gap also limits the potential for innovation and expansion in the market, slowing the growth of minimally invasive treatments and potentially reducing healthcare efficiency.
The COVID-19 pandemic negatively impacted the market, causing delays in elective procedures and disruptions in the global supply chain. Hospitals prioritized urgent care, leading to a decline in demand for non-emergency treatments. Additionally, restrictions on travel and international trade affected the distribution of medical devices. However, the pandemic also accelerated the adoption of telemedicine and remote monitoring, which may indirectly drive future demand for minimally invasive procedures like those involving micro catheters.
The single lumen segment is expected to be the largest during the forecast period
The single lumen segment is expected to account for the largest market share during the projection period. Their simplicity and compact design make them ideal for minimally invasive treatments, offering precise access to target areas, especially in procedures like angioplasty or neurovascular interventions. The growing demand for these catheters is driven by their effectiveness in reducing patient recovery time, minimizing complications, and enabling efficient treatment of various chronic conditions.
The neurovascular segment is expected to have the highest CAGR during the forecast period
The neurovascular segment is expected to have the highest CAGR during the extrapolated period as these devices are crucial for treating conditions like aneurysms, strokes. Micro catheters allow for precise navigation through delicate neurovascular pathways, enabling minimally invasive treatments. Their growing use in neurovascular interventions is driven by advancements in catheter design, improving patient outcomes, reducing recovery time, and offering safer alternatives to traditional surgical methods.
North America region is projected to account for the largest market share during the forecast period driven by advancements in healthcare infrastructure and increasing demand for minimally invasive procedures. The region's strong healthcare system, coupled with technological innovations in micro catheter designs, supports market expansion. Furthermore, the region's aging population and high healthcare expenditure contribute to the growing demand for these devices, making it a key market for micro catheter manufacturers.
Asia Pacific is expected to register the highest growth rate over the forecast period. The expanding healthcare infrastructure, especially in emerging markets, is improving patient access to advanced medical treatments. This is also leading to greater awareness of the benefits of minimally invasive procedures. Additionally, ongoing developments in micro catheter designs, such as improved flexibility, durability, and steerability, have made these devices more effective in treating a wide range of conditions, further driving their adoption.
Key players in the market
Some of the key players in Micro Catheters market include Abbott Laboratories, Medtronic, Johnson & Johnson, Boston Scientific, Terumo Corporation, Stryker Corporation, Cardinal Health, Teleflex Incorporated, Philips Healthcare, Penumbra, Inc., Biotronik, Smith & Nephew, Cook Group, Lumenis, Fujifilm Holdings Corporation and MicroVention, Inc.
In June 2024, MicroVention, Inc. (Terumo Corporation) launched the LVIS EVO, a next-generation coil-assist intracranial stent, in the U.S. It treats wide-neck intracranial aneurysms. It offers enhanced precision and flexibility for neurovascular procedures.
In February 2024, BIOTRONIK and IMDS introduced the Micro RX catheter, a highly flexible microcatheter designed for complex coronary interventions. The catheter enhances precision during procedures, offering greater navigation capabilities in challenging anatomies. Its improved design facilitates optimal performance for clinicians performing intricate vascular procedures.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.